Viatris VTRS
NASDAQ VTRS
$16.08 -0.16 (-0.98%)
At close: Aug 20, 2026 · 12:59 PM UTC

Viatris (VTRS) Revenue Growth (3y) (2022 - 2026)

Viatris (VTRS) Revenue Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn 2.22%
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn 4.22%
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn -0.31%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 9.51%
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -1.40%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 28.43%
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 8.98%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn -7.04%

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.40%
Mar 31, 2026 -2.00%
Dec 31, 2025 -1.48%
Sep 30, 2025 -2.59%
Jun 30, 2025 -4.56%
Mar 31, 2025 -7.99%
Dec 31, 2024 -7.54%
Sep 30, 2024 -6.03%
Jun 30, 2024 -6.02%
Mar 31, 2024 -5.93%
Dec 31, 2023 1.59%
Mar 31, 2023 12.95%
Dec 31, 2022 -29.93%